Graduate School of Medicine, Nagoya University, Nagoya, Japan.
Arch Phys Med Rehabil. 2012 Mar;93(3):485-9. doi: 10.1016/j.apmr.2011.10.021.
To examine the validity of the multistage submaximal cycle ergometer test for adults with athetospastic cerebral palsy.
Cross-sectional and correlative study. Oxygen uptake and heart rates were recorded while the participants underwent the maximal cycle ergometer test and the multistage submaximal cycle ergometer test. Peak oxygen consumption (Vo(2)peak) was achieved by the maximal cycle test. Maximum oxygen consumption (VO(2)max) was predicted by the multistage submaximal cycle ergometer test.
Research laboratory setting.
Adults with athetospastic cerebral palsy (N=16; 10 women and 6 men; mean age ± SD, 43.7±14.5y).
Not applicable.
Peak VO(2) was compared with the predicted VO(2)max.
Mean VO(2)peak and the predicted VO(2)max ± SD were 866.9±202.9 mL/min(-1) and 857.4±248.4 mL/min(-1), respectively. There was not a significant difference between VO(2)peak values and the predicted VO(2)max values (r=.28). And there was a significant correlation between VO(2)peak values and the predicted VO(2)max values (r=.94, P<.001). SE of the estimate (or SE for X to Y) was 71.2 mL/min(-1), equivalent to 7.4%.
The multistage submaximal cycle ergometer test may provide a valid VO(2)max estimate of adults with athetospastic cerebral palsy.
检验多阶段次最大测功计试验在成人手足徐动型脑瘫中的有效性。
横断相关研究。参与者进行最大测功计试验和多阶段次最大测功计试验时，记录耗氧量和心率。最大测功计试验得出峰值耗氧量（Vo(2)peak），多阶段次最大测功计试验预测最大耗氧量（VO(2)max）。
研究实验室环境。
手足徐动型脑瘫成人（N=16；10 名女性和 6 名男性；平均年龄±标准差，43.7±14.5 岁）。
不适用。
峰值 VO(2)与预测 VO(2)max 比较。
平均 Vo(2)peak 和预测 VO(2)max ± SD 分别为 866.9±202.9 mL/min(-1)和 857.4±248.4 mL/min(-1)，VO(2)peak 值与预测 VO(2)max 值之间无显著差异（r=.28），VO(2)peak 值与预测 VO(2)max 值之间有显著相关性（r=.94，P<.001）。估计值的标准误差（或 X 到 Y 的 SE）为 71.2 mL/min(-1)，相当于 7.4%。
多阶段次最大测功计试验可能为手足徐动型脑瘫成人提供 VO(2)max 的有效估计值。
